emocha Mobile Health, a Baltimore, MD-based medication adherence platform provider, closed a $1m seed funding.
Backers included Propel Baltimore Fund, Kapor Capital, Sand Hill Angels, Baltimore Angels, and Blue Jay Syndicate.
The company will use the funds to expand sales efforts and tailor the technology for opioid use disorder treatment.
Led by CEO Sebastian Seiguer, emocha provides a video-based adherence platform powered by healthcare providers. The company work with payers, providers, and health departments to reduce costs and support patients with conditions such as tuberculosis, hepatitis C, and opioid addiction.